Background: Since single lipid parameters are too weak to predict the risk of coronary artery disease, we examined whether the allocation of patients into four groups based on achievement of the target levels set by the Japan Atherosclerosis Guidelines at the time of percutaneous coronary intervention (PCI) would reveal different long-term (5 years) clinical outcomes in males and females. Methods: The results of a 5-year follow-up study are summarized as FU-Registry, Long-Term Clinical Outcome Results. The subjects consisted of 1158 patients who underwent elective PCI. The male and female patients were separately allocated into four groups: (1) high-density lipoprotein cholesterol (HDL-C ! 40 mg/dl as well as low-density lipoprotein-cholesterol (LDL-C) ! 100 mg/dl); (2) HDL-C ! 40 mg/dl as well as LDL-C < 100 mg/dl; (3) HDL-C < 40 mg/dl as well as LDL-C ! 100 mg/dl; (4) HDL-C < 40 mg/dl as well as LDL-C < 100 mg/dl, for a comparison of both patient as well as lesion characteristics and the endpoint of major adverse cardiac events (MACEs). Results: Regarding lesion characteristics, significant differences (p < 0.05) were detected in the usage rate of a drug-eluting stent (DES) as well as the bend, stent reference diameter, and stent minimum lumen diameter in females by ANOVA, and in severe calcification, the bend, and usage rate of DES (p < 0.001) in males. In females, significant differences (p < 0.05) were observed in MACEs and target lesion revascularization-PCI. In contrast, among males, the four groups had nearly equivalent outcomes. Uni-and multivariate analyses revealed that HDL-C as well as LDL-C in females were associated with MACEs [OR 3.29 (95% CI 1.05-8.57, p = 0.04)], while no association was observed in male multivariate analysis. Conclusion: In female patients, HDL-C < 40 mg/dl and LDL-C ! 100 mg/dl were even more strongly related to MACEs, whereas the combination of LDL-C and HDL-C was not related to MACEs in male patients.
Heart disease is the second most frequent cause of death among Japanese following malignant neoplasm. According to a report by the Ministry of Health, Labour and Welfare, it affected approximately 200,000 individuals in 2013, mostly as coronary artery disease (CAD) [1] . Because lethal CAD including myocardial infarction is mainly associated with coronary atherosclerosis, aggressive lipid-lowering therapy is especially important for highrisk patients or for the secondary prevention of CAD.
Several articles have reported that both the incidence and mortality of CAD differ between males and females [2] [3] [4] [5] . However, the correlations between the incidence of CAD and cholesterolrelated parameters, including positive and negative correlations of CAD with low-density lipoprotein cholesterol (LDL-C) and highdensity lipoprotein cholesterol (HDL-C), respectively, are the same in males and females [2] [3] [4] [5] [6] [7] . The Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012 [8] set the same target control levels of lipid-related parameters [LDL-C, HDL-C, non HDL-C, and triglycerides (TG)] in both males and females for primary and secondary prevention. However, the US "National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATP III)" [9] and "Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women" [10] , published in the USA in 2001 and 2004, respectively, prescribe a target control value of HDL-C in primary prevention of 50 mg/dl for females and >40 mg/dl for males. Later, the American College of Cardiology/American Heart Association guidelines [11] showed that there was insufficient evidence to support treatment to achieve specific LDL-C or non-HDL-C goals, i.e. there is no evidence using treat to target, while the European Society of Cardiology (ESC) guidelines [12] and National Lipid Association (USA) [13] support the use of target levels of lipid parameters. As for HDL-C, JAS stated that there is a sex difference in HDL-C levels, but, since there are insufficient data in females to draw any definitive conclusions, further investigations will be needed [8] . Additionally, little is known about whether there is a difference between males and females in the secondary prevention of CAD and the long-term clinical outcomes of patients after PCI.
Because the incidence of CAD in females is likely to increase as the population continues to age, it is important that we understand this sex difference and its mechanism. Therefore, we hypothesized that the relationship between the development of major adverse cardiac events (MACEs) after PCI and the target level of each cholesterol-related parameter differs between males and females, and multiple cholesterol-related parameters (HDL-C < 40 mg and LDL-C ! 100 mg) are more closely related to the development of MACEs after PCI than HDL-C and LDL-C by themselves in both males and females. In this study, we verified this hypothesis using our PCI-Registry of FU-Registry: Long-Term Clinical Outcome Results (LTCOR).
Methods

Patients
Among 2832 cases in our PCI registry (FU-Registry) [14] , 1628 patients in whom PCI was performed at Fukuoka University, Fukuoka University Chikushi Hospital, or Hakujyuji Hospital allowed us to conduct a long-term follow-up study, even after follow-up coronary angiography (CAG) 9-12 months after PCI, and were enrolled as FU-Registry: Long-Term Clinical Outcome Results (LTCOR). From among these 1628 cases, 329 cases of acute coronary syndrome (ACS) and 141 under maintenance hemodialysis (HD) were excluded, which left 1158 cases as subjects in whom elective PCI was performed (Fig. 1) . The male and female patients were separately allocated into four groups: (1) HDL-C ! 40 mg/dl as well as LDL-C ! 100 mg/dl; (2) HDL-C ! 40 mg/dl as well as LDL-C < 100 mg/dl; (3) HDL-C < 40 mg/dl as well as LDL-C ! 100 mg/dl; and (4) HDL-C < 40 mg/dl as well as LDL-C < 100 mg/dl (125, 85, 32, and 23 females and 334, 253, 169, and 137 males, respectively) using LDL-C: 100 mg/dl and HDL-C: 40 mg/dl as cut-off values, according to the target levels of secondary prevention in the JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012 [8] , for a comparison of patient as well as lesion characteristics (angiographical quantitative and qualitative analyses). The endpoint was major adverse cardiac events (MACEs), which were defined as all-cause death, myocardial infarction, and target lesion revascularization (TLR). The median follow-up period of the subject group was 1092 AE 790 days. All patients underwent clinical follow-up, which terminated 5 years after PCI. The presence or absence of MACE was confirmed at the final outpatient visit or by telephone communication, which was performed between several physicians in charge and the patients' family members. The details of other (soft) endpoints were obtained when the patients were hospitalized. Myocardial infarction included both ST-T elevation myocardial infarction and non-ST-T elevation myocardial infarction, and had to either show evident ischemic electrocardiographic change or cardiogenic enzyme level elevation [troponin T positive by a simple test, creatine kinase (CK) twice as high as the reference level or higher, and/or CK-MB higher than the upper limit of the reference level].
Percutaneous coronary intervention procedure PCI was performed for patients who had above 50% angiographic stenosis, any chest symptom, or ischemia by non-invasive examination (treadmill stress testing and/or myocardial scintigraphy) or by the fractional flow reserve (FFR). The technical endpoints were to be a lack of dissection that could cause impeded blood flow, achievement of Thrombolysis in Myocardial Infarction III flow, and angiographic degree of stenosis 10%, as described previously [14] [15] [16] .
Medications (antiplatelets)
Regarding medications (antiplatelets), aspirin, and either ticlopidine 200 mg or clopidogrel 75 mg were started at least 48 h before stent implantation in all cases. In principle, in bare metal stent cases, antiplatelets other than aspirin were continued for at least 4 weeks, whereas with a drug-eluting stent (DES), all antiplatelets were administered for at least 12 months postoperatively, as described previously [14] [15] [16] .
Quantitative coronary angiography
All patients underwent quantitative coronary angiography (QCA) for analysis of pre-and post-procedural angiograms. Quantitative and qualitative analyses were conducted in the core laboratory, Fukuoka University, using CMS-GFT and Q-Angio XA Ver. 7.1 (MEDIS, Leiden, The Netherlands). All measurements used a contrast material following the intracoronary injection of nitroglycerin. Segments were defined to be the stent segment and the 5-mm segments proximal and distal to the stent edges, as described previously [14] [15] [16] .
Statistical analysis
All statistical data analyses were performed at Fukuoka University using SAS software (SAS 9.4 Institute Inc, Cary, NC, USA). Categorical variables were expressed as percentages [14] [15] [16] . The differences in categorical variables among groups were examined by a Chi-square analysis. Continuous variables were expressed as mean AE SD. The differences in continuous variables among groups were examined by analysis of variance (ANOVA) and multiple comparisons tests. The multivariate analysis used a multiple logistic regression analysis. A p-value <0.05 was considered to be statistically significant.
Results
Patients and lesion characteristics
Among females, a multi-group comparison by ANOVA revealed that the patient characteristics, except for systolic blood pressure (SBP) and smoking (SBP: p = 0.01; smoking: p < 0.001), were nearly equivalent among the four groups. With regard to the blood sampling test results, significant differences were detected in the levels of cholesterol-related parameters among the four groups (total cholesterol: p < 0.001; TG: p < 0.001; HDL-C: p < 0.001; LDL-C: p < 0.001; LDL-C/HDL-C ratio: p < 0.001; non-HDL-C: p < 0.001). In addition, significant differences were detected with respect to prior PCI (p = 0.04), hypertension (p = 0.002), the rate of statin use (p < 0.001), the bend (p = 0.04), and the rate of DES use (p = 0.02). Significant differences were also detected in stent reference diameter (p = 0.02), and stent minimum lumen diameter (MLD) in the QCA results (p = 0.04) (Table 1A) .
Among the patient characteristics in males, significant differences were detected in the level of each cholesterol-related parameter among the four groups, as in females (Table 1B ). Significant differences were also detected among the four groups with respect to age (p < 0.001), BMI (p = 0.01), systolic blood pressure (SBP) (p = 0.01), diastolic blood pressure (DBP) (p = 0.02), smoking (p = 0.01), and left ventricular ejection fraction (LVEF) by ultrasound cardiography (UCG) (p = 0.003). The incidence of prior diseases/complications was nearly equivalent among the four groups, except for prior PCI (p < 0.001). Significant differences were also detected in rates of statin (p < 0.001) and calcium 2+ channel blocker use (p = 0.04) (Table 1B) . Regarding lesion characteristics, significant differences were detected in severe calcification (p = 0.01), the bend (p = 0.04), and rate of DES use (p < 0.001), whereas the QCA results were nearly equivalent among the four groups (Table 1B) .
Long-term clinical outcomes
Regarding the long-term clinical outcomes in females, significant differences were observed in MACEs (p = 0.02) and TLR-PCI (p = 0.03), and the outcomes were generally worst in the HDL-C < 40 mg/dl and LDL-C ! 100 mg/dl group (Table 2A) . In contrast, among males, the four groups had nearly equivalent long-term clinical outcomes (Table 2B) .
Multivariate logistic regression analysis
The risk for the incidence of MACEs in cases in which the target control levels of cholesterol-related parameters for secondary prevention according to the JAS Guidelines were not achieved at the time of PCI, as well as in cases in which both LDL-C and HDL-C did not reach the respective target values (LDL-C ! 100 mg/dl and HDL-C < 40 mg/dl), was assessed by uni- (Fig. 2 ) and multivariate analyses separately in males and females, by considering the influences of various patient and lesion characteristics, and the strength of the relationships of MACE with HDL-C < 40 mg/dl, LDL-C ! 100 mg/dl, and both HDL-C < 40 mg/dl and LDL-C ! 100 mg/dl (Tables 3A and 3B ). Female Model 1 was for the univariate analysis of HDL-C < 40 mg/dl and LDL-C ! 100 mg/dl, HDL-C < 40 mg/dl, and LDL-C ! 100 mg/dl. In the analyses using Models 2-4,several parameters were added to each of these three groups (Table 3A) . In males, Model 1 was used for the univariate analysis of the three parameters above as in females. In the analyses using Models 2-4, the several parameters were added to each of these three groups (Table 3B) .
As a result, HDL-C and LDL-C in females showed OR 3.29 (95% CI 1.05-8.57, p = 0.04), indicating a strong relationship with MACEs ( Table 3A , adjusted for general variables and QCA data, etc.). Among parameters other than HDL-C and LDL-C, smoking and DES were strongly related to MACE in all models: in Model 4 on HDL-C and LDL-C, ORs of smoking and DES were 2.66 (95% CI 1.01-6.99, p = 0.04) and 0.96 (95% CI 0.80-0.92, p = 0.02), respectively (Table 3A ) (data not tabulated). In males, neither HDL-C < 40 mg/dl, LDL-C ! 100 mg/dl, nor HDL-C and LDL-C showed any relationship with MACEs in the multivariate analysis ( Table 3B ). In males, LDL-C ! 100 mg/dl was significantly related to MACEs only in the univariate analysis using Model 1. While the QCA results were nearly equivalent among the four groups in males, neither HDL-C and LDL-C nor HDL-C < 40 mg/dl was related to MACEs in any of the models. In addition, UCG-LVEF and DES were strongly related to MACEs in males: in Model 4 on LDL-C 100 mg/ dl, ORs of UCG-LVEF and DES were 0.97 (95% CI 0.96-0.99, p = 0.01) and 0.90 (95% CI 0.85-0.95, p < 0.001), respectively (Table 3B ) (data not tabulated).
Discussion
As a result, a univariate analysis of female patients revealed that HDL-C < 40 mg/dl tended to be positively associated with the development of MACEs after PCI (Fig. 2 and Table 3A) . Moreover, the combination of multiple parameters, LDL-C ! 100 mg/dl and HDL-C < 40 mg/dl, was found to be a stronger predictor of the development of MACEs, and was proven to be strongly related to MACEs by a multivariate analysis. Meanwhile, a univariate analysis of male patients revealed that LDL-C ! 100 mg/dl at the time of PCI was positively and significantly associated with the development of MACEs, whereas both the combination of HDL-C and LDL-C, and HDL-C < 40 mg/dl, which showed significant differences in females, were not related to MACEs (Fig. 2 and Table 3B) .
HDL-C is higher in females than in males throughout life by approximately 10 mg/dl [10] , although this difference decreases rapidly at 50 years of age. The influence of female menopause, and particularly of the hormone estrogen, is considered to be a main cause of such sex differences in plasma lipid parameter levels. Estrogen has been reported to have various protective actions on cardiac vessels [17, 18] . It is generally accepted that this antiarteriosclerotic action of endogenous estrogen can explain why the incidence of CAD is lower in premenopausal females than in males [19] . Heer et al. recently reported sex differences in PCI in-hospital outcomes from a large registry study, and stated that women have a 20% higher risk of MACEs [20] .
It has been reported that low HDL-C is more useful for predicting the risk of CAD than high LDL-C in females [21] . It has been also reported that low HDL-C with low functionality of HDL [22] , or low HDL-C with high CRP [23] , is more useful for predicting the risk of CAD than high LDL-C after adjusting for gender. In Japan, there is a problem with the use of a common target HDL-C level (>40 mg/dl) in both females and males because HDL-C levels are thought to be higher in females than in males throughout life. In this study, HDL-C < 40 mg/dl and LDL-C ! 100 mg/dl were significantly related to TLR-PCI and MACEs in females (Table 2A) . This phenomenon is also observed after adjustment for patient characteristics and QCA or lesion parameters (Table 3A) . Definite reason is unclear, but coronary lesion in females is likely to be affected by dyslipidemia. In addition, this study also indicated that the combination of LDL-C and HDL-C is more useful than HDL-C alone for predicting the development of MACEs in females, consistent with the results of the Framingham Heart Study [24] that comprehensive assessment using multiple parameters including HDL-C was important for managing the risk of CAD. Although it is ideal in theory for both LDL-C and HDL-C to have reached their respective target control levels by the time of PCI in both males and females, the incidence of MACEs in females was lower when either LDL-C or HDL-C reached its target level than when neither did so. The incidence of MACEs in males was much lower when LDL-C was controlled than when neither LDL-C nor HDL-C achieved their respective target levels (Tables 2A and 2B ). Statin therapy with proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors has been shown to induce a drastic reduction of LDL-C, which actually was associated with the reduction of MACEs [25] and the regression of coronary atherosclerosis [26] , in which more than 75% were male patients studied.
For females with low HDL-C levels as well as high LDL-C levels, who are likely to be at particularly high risk of post-PCI development of MACEs, it is important to initially attempt to control LDL-C by means of statin administration, although this may be insufficient. At present, there are many uncertainties regarding therapeutic intervention for HDL-C in primary and secondary prevention, since recent studies have indicated that therapeutic interventions targeting HDL-C should be avoided [27] . Since strategies for increasing HDL-C by medications including niacin [28] , fibrate drugs [29] , cholesteryl ester transfer protein inhibitors [30] , etc., may not help to reduce hard endpoints, even if LDL-C reaches its target level, additional studies will be required. However, lifestyle modifications, such as smoking cessation and dietary counseling with exercise, are likely to be important in both primary and secondary prevention and in both females and males.
Limitations
This is a registry study in patients who underwent PCI from 2003 to 2011 and whose subsequent 5-year course could be followed up. Although the female patients were likely to include many postmenopausal patients, judging from their mean age, the presence or absence of menopause could not be surveyed accurately, and female hormones including estrogen were not assayed. While the sample size of men is adequate, that of females Fig. 2 . The relationship between cholesterol-related parameters and major adverse cardiac events was examined by a univariate logistic regression analysis. HDL-C, highdensity lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; OR, odds ratio; T-cho, total cholesterol; TG, triglycerides. is rather small, however, we can currently perform a minimal analysis. In addition, the subjects of this analysis included patients who themselves or whose families were interviewed by telephone to determine whether or not they developed any MACEs, patients with sudden death, and patients who were transported to other hospitals because of MACEs. Their detailed follow-up data including breakdown of death, lipid-related parameter levels at the time of MACE development and final follow-up, controllability of dyslipidemia after PCI, and oral medication condition could not be collected. Patient follow-up was mainly performed by other local outpatient clinics, and detailed examinations were not always well performed. The laboratory data at PCI were available for all patients and we used these data.
Conclusion
In females, compared to LDL-C ! 100 mg/dl, HDL-C < 40 mg/dl at the time of PCI was more strongly related to MACEs after PCI, but HDL-C < 40 mg/dl as well as LDL-C ! 100 mg/dl, i.e. the combination of LDL-C and HDL-C, was even more strongly related to MACEs. On the other hand, in males, among the cholesterol-related parameters, LDL-C ! 100 mg/dl was found to be most strongly related to MACEs, whereas the combination of LDL-C and HDL-C was not related to MACEs. This sex difference likely arises from the fact that the same target control levels are set despite a sex difference in the normal ranges of cholesterol-related parameters. This study suggests that it likely would be useful to strictly control LDL-C before PCI in both males and females to, in turn, limit the post-PCI development of MACE as well as to strictly control HDL-C in females. 
